Novartis Investigative Site

Bend, Oregon 97701

0 studies enrolling now · 5 studies all time

What they study most

Atherosclerosis, COVID-19 Pneumonia, Impaired Respiratory Function, Coronary Artery Disease (CAD), Coronary Atherosclerosis, Melanoma, Rheumatoid Arthritis

Studies at this site

• Study of Efficacy and Safety of MAS825 in Patients With COVID-19 — Completed
• Dabrafenib Plus Trametinib vs Vemurafenib Alone in Unresectable or Metastatic BRAF V600E/K Cutaneous Melanoma — Completed
• Cardiovascular Risk Reduction Study (Reduction in Recurrent Major CV Disease Events) — Completed
• Double Blind, Placebo-controlled, Study of the Safety, Tolerability and Pharmacokinetics of AIN457 in Rheumatoid Arthritis Patients — Completed
• Safety and Efficacy of Aliskiren on the Progression of Atherosclerosis in Coronary Artery Disease Patients — Completed